$12.00
-0.34[-2.76%]
At close: Apr 22
$12.00
0[0.00%]
After Hours: 4:11PM EDT
Greenwich LifeSciences
(NASDAQ:GLSI)Latest News for Greenwich LifeSciences Stock (NASDAQ:GLSI)
Greenwich LifeSciences Stock (NASDAQ: GLSI)
Categories: All
Monday, April 22, 2024
Monday, March 25, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Thursday, February 22, 2024
Tuesday, February 20, 2024
Wednesday, February 14, 2024
- Why Greenwich Lifesciences (GLSI) Stock Is SkyrocketingHenry Khederian - Feb 14, 2024, 2:09PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 14, 2024, 12:31PM
- Greenwich LifeSciences shares are trading higher after the company provided an update on the Phase III clinical trial, Flamingo-01.Benzinga Newsdesk - Feb 14, 2024, 12:27PM
- Greenwich Lifesciences Provided An Update On Phase 3 Flamingo-01 Trial Of GLSI-100 Cancer ImmunotherapyBenzinga Newsdesk - Feb 14, 2024, 6:07AM
Monday, October 02, 2023
Friday, July 21, 2023
Monday, April 10, 2023
Wednesday, January 11, 2023
Friday, November 25, 2022
Monday, October 24, 2022
Monday, October 17, 2022
Monday, October 10, 2022
Monday, October 03, 2022
Monday, September 19, 2022
Monday, September 12, 2022
Monday, August 22, 2022
Thursday, August 11, 2022
Monday, August 08, 2022
Wednesday, August 03, 2022
Wednesday, July 13, 2022
- Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jul 13, 2022, 12:21PM
- This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving PremarketLisa Levin - Jul 13, 2022, 6:22AM
- Boeing, PriceSmart And 80 Biggest Movers From YesterdayLisa Levin - Jul 13, 2022, 4:59AM
Tuesday, July 12, 2022
- Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike HigherLisa Levin - Jul 12, 2022, 2:39PM
- Here's Why Greenwich Lifesciences Shares Are Popping Off TodayHenry Khederian - Jul 12, 2022, 1:07PM
- U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 ResultsLisa Levin - Jul 12, 2022, 12:02PM
- Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jul 12, 2022, 12:00PM
- Greenwich LifeSciences shares are trading higher after the FDA removed the clinical hold on the company's Flamingo-01 Phase 3 trial of GP2.Bill Haddad - Jul 12, 2022, 11:28AM
- Why Markets Are Trading Mixed; US Small Business Optimism Tumbles To This LevelLisa Levin - Jul 12, 2022, 10:18AM
- The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data SoonerVandana Singh - Jul 12, 2022, 9:04AM
- Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to ProceedBill Haddad - Jul 12, 2022, 6:00AM
Monday, July 11, 2022
- UPDATE: Greenwich LifeSciences Says FDA Is Currently Reviewing Manufacturing Data, Has Sent Co. Follow Up Questions To Which Co. Has Responded; Co. Says 3rd Lot Was Manufactured In Commercial Facility On Automated Filling LineMichael Horton - Jul 11, 2022, 5:11PM
- Greenwich LifeSciences Says Completed Last Steps Of Manufacturing GP2, Says Released Three Clinical Lots Of GP2 Drug Product That Co. Believes Meet All Release SpecificationsMichael Horton - Jul 11, 2022, 5:10PM
- Greenwich LifeSciences Announces Suspension of Share Repurchase ProgramBill Haddad - Jul 11, 2022, 4:16PM
Tuesday, June 28, 2022
Monday, June 13, 2022
Friday, June 10, 2022
Wednesday, June 01, 2022
Monday, May 23, 2022
- Greenwich LifeSciences To Resume Stock Repurchase ProgramBenzinga Newsdesk - May 23, 2022, 7:11AM
- Greenwich LifeSciences Announces FDA Review Of Manufacturing Plans And Pharmacy Procedures Associated With A Recently Placed Clinical Hold On The FLAMINGO-01 Phase III Clinical Trial Is UnderwayBenzinga Newsdesk - May 23, 2022, 6:05AM